Evidence map›Paper›PMID 31151252›Full record

ArticleBiomolecules2019

Gels of Amyloid Fibers.

Ruizhi Wang, Xiaojing Yang, Lingwen Cui, Hang Yin, Shaohua Xu

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ruizhi WangDepartment of Biomedical & Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, FL 32901, USA. wangr2011@my.fit.edu.
Xiaojing YangDepartment of Biomedical & Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, FL 32901, USA. xyang2008@my.fit.edu.
Lingwen CuiDepartment of Biomedical & Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, FL 32901, USA. lcui2011@my.fit.edu.
Hang YinDepartment of Biomedical & Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, FL 32901, USA. hyn2011@my.fit.edu.
Shaohua XuDepartment of Biomedical & Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, FL 32901, USA. shaohua@fit.edu.
Florida Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein self-assembly and formation of amyloid fibers is an early event of numerous human diseases. Continuous aggregation of amyloid fibers in vitro produces biogels, which led us to suspect that amyloid plaques and neurofibrillary tangles in Alzheimer's disease are of biogels in nature. We applied atomic force microscopy, size exclusion chromatography, and differential scanning calorimetry to elucidate the gel's structure, kinetics of gel formation, and melting point. We found that (1) lysozyme gelation occurs when the protein concentration is above 5 mg/mL; (2) nonfibrous protein concentration decreases and plateaus after three days of gel synthesis reaction; (3) colloidal lysozyme aggregates are detectable by both atomic force microscopy (AFM) and fast protein liquid chromatography (FPLC); (4) the gels are a three-dimensional (3D) network crosslinked by fibers coiling around each other; (5) the gels have a high melting point at around around 110 °C, which is weakly dependent on protein concentration; (6) the gels are conductive under an electric field, and (7) they form faster in the presence than in the absence of salt in the reaction buffer. The potential role of the gels formed by amyloid fibers in amyloidosis, particularly in Alzheimer's disease was thoroughly discussed, as gels with increased viscosity, are known to restrict bulk flow and then circulation of ions and molecules.

Indexed as

Protein AggregatesAmyloidAnimalsGelsMuramidaseTransition TemperatureAmyloidGelsMuramidaseProtein AggregatesAlzheimer’s diseaseamyloidosisamyloid plaqueatomic force microscopydementiaprotein aggregationprotein colloids

Identifiers

PMID31151252
PMCPMC6628346
OpenAlexW2947858702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.